Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging

INTRODUCTION: The diagnostic pathway after a negative magnetic resonance imaging (nMRI) exam is not clearly defined. The aim of the present study is to define the risk of prostate adenocarcinoma (PCa) at the prostate biopsy after a negative multiparametric magnetic resonance imaging (mpMRI) exam. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zattoni, Fabio, Morlacco, Alessandro, Soligo, Matteo, Mancini, Mariangela, Leone, Nicolò, Zecchini, Giovanni, Reitano, Giuseppe, Bednarova, Iliana, Lacognata, Carmelo Salvino, Lauro, Alberto, Zanovello, Nicola, Novara, Giacomo, dal Moro, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628724/
https://www.ncbi.nlm.nih.gov/pubmed/36381166
http://dx.doi.org/10.5173/ceju.2022.0092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628724/
https://www.ncbi.nlm.nih.gov/pubmed/36381166
http://dx.doi.org/10.5173/ceju.2022.0092

Ejemplares similares